Martingale Asset Management »

Neurocrine Biosciences shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $92k 12k 7.54

More positions owned by Martingale Asset Management

Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Facebook Inc cl a (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Berkshire Hathaway (BRK.B)
At&t (T)
Exxon Mobil Corporation (XOM)
Visa (V)
Cisco Systems (CSCO)
MasterCard Incorporated (MA)
Wal-Mart Stores (WMT)
Verizon Communications (VZ)

View all positions for Martingale Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management
UBS Group

View all funds holding Neurocrine Biosciences